BICO’s Calendar for financial reporting: H2 2024 and 2025
October 18, 2024 7:00 amBICO Group AB 559050–5052 (NASDAQ STOCKHOLM: BICO)
BICO’s Calendar for financial reporting: H2 2024 and 2025
- Q3 report 2024: November 26, 2024, 7am CET
- Year-end report 2024: February 19, 2025, 7am CET
- Annual Report 2024: March 20, 2025, to be released during the day
- Q1 report 2025: April 29, 2025, 7am CEST
- Annual General Meeting 2025: May 8, 2025. Time to be announced in notice to AGM 2025
- Q2 report 2025: August 19, 2025, 7am CEST
- Q3 report 2025: November 4, 2025, 7am CET
- Year-end report 2025: February 10, 2026, 7am CET
Please note that, as communicated during the Capital Markets Day and due to the new business area structure, BICO’s Q3 report 2024 will be released on Tuesday November 26, 2024, at 7am CET.
For further information, please contact:
Jacob Thordenberg, CFO, BICO Group AB
Phone: +46 735 34 88 84
E-mail: jt@bico.com
The information was submitted for publication, through the agency of the contact person set out above, on October 18, 2024 at 7am CEST.
BICO is a lab automation partner and provider of selected workflows to pharma and biotech. With 46,000+ instruments installed in over 65 countries, BICO products, software, and solutions are found in more than 3,500 laboratories, including the world’s top 20 pharmaceutical companies, and have been cited in over 12,000 publications. Operating through three business areas – Lab Automation, Life Science Solutions, and Bioprinting – BICO strives towards the vision to enable and automate the life science lab of the future. BICO is listed on Mid-Cap, Nasdaq Stockholm under BICO. www.bico.com